Tenomix Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Tenomix Inc. - overview
Established
2021
Location
London, ON, Canada
Primary Industry
Medical Devices & Equipment
About
Based in Ontario, Canada, Founded in 2021, Tenomix Inc. operates as a medical equipment company that designs and develops medical equipment. The company was founded by its CEO, Saumik Biswas, COO Eveline Pasman, CBO Sherif Abdou, and Michael Lavdas. In November 2023, Tenomix Inc.
raised venture funding from the Fight Against Cancer Innovation Trust. Tenomix designs and manufactures medical devices for cancer patients. The company’s product line includes the Lymphonator, which is an automated robotic scanning device for identifying lymph nodes in colorectal cancer patients. The device employs sophisticated imaging technology to automatically identify and mark lymph nodes in the specimen, facilitating their extraction for further analysis.
The company plans to use the funds raised in November 2023 for developing and commercializing its Lymphonator bench-top robotic scanning device.
Current Investors
Fight Against Cancer Innovation Trust, FACIT
Primary Industry
Medical Devices & Equipment
Sub Industries
Oncology/Cancer Treatment, Monitoring Equipment, Diagnostic Equipment, Medical Software
Website
www.tenomix.com
Verticals
Manufacturing, Robotics
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.